Limited Liability Partnership Registration No. SO302843 (Scotland)
TAYCARE HEALTH (MANAGEMENT) LLP
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
TAYCARE HEALTH (MANAGEMENT) LLP
LIMITED LIABILITY PARTNERSHIP INFORMATION
Designated members
Cobalt CPI Limited
Cobalt Project Investments (Taycare) Limited
Limited liability partnership number
SO302843
Registered office
Exchange Tower
11th Floor
19 Canning Street
Edinburgh
EH3 8EH
Auditor
Johnston Carmichael LLP
7-11 Melville Street
Edinburgh
EH3 7PE
Solicitors
Pinsent Masons Secretarial Limited
13 Queen's Road
Aberdeen
AB15 4YL
TAYCARE HEALTH (MANAGEMENT) LLP
CONTENTS
Page
Members' report
1
Members' responsibilities statement
2
Independent auditor's report
3 - 5
Statement of comprehensive income
6
Balance sheet
7
Reconciliation of members' interests
8
Notes to the financial statements
9 - 12
TAYCARE HEALTH (MANAGEMENT) LLP
MEMBERS' REPORT
FOR THE YEAR ENDED 31 MARCH 2023
- 1 -

The members present their annual report and financial statements for the year ended 31 March 2023.

Principal activities

The principal activity of the limited liability partnership is to provide support services to Taycare Health Limited.

The principal activities of Taycare Health Limited are the financing, design and construction of and the provision of certain services in connection with the Tayside Mental Health Developments Project through an agreement with Tayside Health Board (Legal Organisation). The agreement was entered into under the Government’s Private Finance Initiative Scheme.

 

Designated members

The designated members who held office during the year and up to the date of signature of the financial statements were as follows:

Cobalt CPI Limited
A Member
Cobalt Project Investments (Taycare) Limited
B Member

Transactions with members

 

Initial capital

 

A Member        £50

B Member        £50

 

Auditor

The auditor, Johnston Carmichael LLP, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Statement of disclosure to auditor

Each of the members in office at the date of approval of this annual report confirms that:

 

Small LLPs exemption

This report has been prepared in accordance with the special provisions relating to small LLPs within Part 15 of the Companies Act 2006.

Approved by the members on 13 October 2023 and signed on behalf by:
13 October 2023
John McDonagh
John McDonagh
Cobalt CPI Limited
Cobalt Project Investments (Taycare) Limited
Designated Member
Designated Member
TAYCARE HEALTH (MANAGEMENT) LLP
MEMBERS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 MARCH 2023
- 2 -

The members are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 (the 2008 Regulations) requires the members to prepare financial statements for each financial year. Under that law the members have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law).

 

Under the 2008 Regulations, the members must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the limited liability partnership and of the profit or loss of the limited liability partnership for that period.

 

In preparing those financial statements, the members are required to:

  1. Select suitable accounting policies and then apply them consistently;

  2. Make judgements and estimates that are reasonable and prudent; and

  3. Prepare the financial statements on the going concern basis unless it is inappropriate to presume that the limited liability partnership will continue in business.

 

Under the 2008 Regulations the members are responsible for keeping adequate accounting records that are sufficient to show and explain the limited liability partnership’s transactions and disclose with reasonable accuracy at any time the financial position of the limited liability partnership and to enable them to ensure that the financial statements comply with the requirements of those Regulations. They are also responsible for safeguarding the assets of the limited liability partnership and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

These responsibilities are exercised by the designated members on behalf of the member.

TAYCARE HEALTH (MANAGEMENT) LLP
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF TAYCARE HEALTH (MANAGEMENT) LLP
- 3 -
Opinion

We have audited the financial statements of Taycare Health (Management) LLP (‘the company’) for the year ended 31 March 2023, which comprise the Statement of Other Comprehensive Income, Balance Sheet, the reconciliation of members’ interest and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the Members’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the Members with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the Annual Report other than the financial statements and our auditor’s report thereon. The Members are responsible for the other information contained within the Annual Report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

TAYCARE HEALTH (MANAGEMENT) LLP
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF TAYCARE HEALTH (MANAGEMENT) LLP
- 4 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Members’ Report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of members

As explained more fully in the Members’ Responsibilities Statement set out on page 2, the Members are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Members determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the Members are responsible for assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Members either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: http://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Extent the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

We assessed whether the engagement team collectively had the appropriate competence and capabilities to identify or recognise non-compliance with laws and regulations by considering their experience, past performance and support available.

All engagement team members were briefed on relevant identified laws and regulations and potential fraud risks at the planning stage of the audit. Engagement team members were reminded to remain alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

We obtained an understanding of the legal and regulatory frameworks that are applicable to the company and the sector in which it operates, focusing on those provisions that had a direct effect on the determination of material amounts and disclosures in the financial statements. The most relevant frameworks we identified include:

TAYCARE HEALTH (MANAGEMENT) LLP
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF TAYCARE HEALTH (MANAGEMENT) LLP
- 5 -

We gained an understanding of how the company is complying with these laws and regulations by making enquiries of management and those charged with governance. We corroborated these enquiries through our review of relevant correspondence with regulatory bodies and board meeting minutes.

We assessed the susceptibility of the financial statements to material misstatement, including how fraud might occur, by meeting with management and those charged with governance to understand where it was considered there was susceptibility to fraud. This evaluation also considered how management and those charged with governance were remunerated and whether this provided an incentive for fraudulent activity. We considered the overall control environment and how management and those charged with governance oversee the implementation and operation of controls. We identified a heightened fraud risk in relation to:

In addition to the above, the following procedures were performed to provide reasonable assurance that the financial statements were free of material fraud or error:

Our audit procedures were designed to respond to the risk of material misstatements in the financial statements, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve intentional concealment, forgery, collusion, omission or misrepresentation. There are inherent limitations in the audit procedures performed and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it.

 

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Allison Dalton (Senior Statutory Auditor)
For and on behalf of Johnston Carmichael LLP
10 November 2023
Chartered Accountants
Statutory Auditor
7-11 Melville Street
Edinburgh
EH3 7PE
TAYCARE HEALTH (MANAGEMENT) LLP
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2023
- 6 -
2023
2022
Notes
£
£
Turnover
2
706,496
655,837
Operating expenses
(706,496)
(655,837)
Profit for the financial year before members' remuneration and profit shares available for discretionary division among members
-
0
-
0

The result for the year arises from the limited liability partnership’s continuing activities.

TAYCARE HEALTH (MANAGEMENT) LLP
BALANCE SHEET
AS AT
31 MARCH 2023
31 March 2023
- 7 -
2023
2022
Notes
£
£
£
£
Current assets
Debtors falling due after more than one year
5
100
100
Debtors falling due within one year
5
312,415
-
312,515
100
Creditors: amounts falling due within one year
Other creditors
6
312,415
-
Net current assets and net assets attributable to members
100
100
Represented by:
Loans and other debts due to members within one year
7
Members' capital classified as a liability
100
100

These financial statements have been prepared in accordance within the specified provisions of the Companies Act 2006 (as applied to the Limited Liability Partnerships (accounts and audit) (application of the Companies Act 2006) Regulations 2008) applicable to LLPs subject to the small LLPs regime.

 

The financial statements were approved by the members and authorised for issue on 13 October 2023 and are signed on their behalf by:
13 October 2023
John McDonagh
John McDonagh
Cobalt CPI Limited
Cobalt Project Investments (Taycare) Limited
A Representative
B Representative
Limited Liability Partnership Registration No. SO302843
TAYCARE HEALTH (MANAGEMENT) LLP
RECONCILIATION OF MEMBERS' INTERESTS
FOR THE YEAR ENDED 31 MARCH 2023
- 8 -
Current financial year
Members' Interest
Members' capital
Total
2023
£
Members' interests at 1 April 2022
100
100
Members' interests at 31 March 2023
100
100
TAYCARE HEALTH (MANAGEMENT) LLP
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
- 9 -
1
Statement of compliance

The individual financial statements of Taycare Health (Management) LLP have been prepared in compliance with United Kingdom Accounting Standards, including Financial Reporting Standard 102, ‘‘The Financial Reporting Standard applicable in the United Kingdom and the Republic of Ireland’’ (‘‘FRS 102’’) and the requirements of the Companies Act 2006 as applicable to limited liability partnerships by the Limited Liability Partnerships (Accounts and Audit)(Application at Companies Act 2006) regulations 2008 subject to the small LLPs regime.

 

General information

 

Taycare Health (Management) LLP is a Limited Liability Partnership domiciled in Scotland. The address of its registered office is Exchange Tower, 11th Floor, 19 Canning Street, Edinburgh, Scotland, EH3 8EH.

The LLP provides Support Services to Taycare Health Limited.

The principal activities of Taycare Health Limited are the financing, design and construction of and the provision of certain services in connection with the Tayside Mental Health Developments Project through an agreement with Tayside Health Board (Legal Organisation). The agreement was entered into under the Government’s Private Finance Initiative Scheme.

 

The limited liability partnership’s functional and presentation currency is the pound sterling. Monetary amounts in these financial statements are rounded to the nearest pound.

 

1.1
Accounting policies

The financial statements have been prepared under the historic cost convention in accordance with applicable accounting standards including FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland (“FRS 102”) and the Statement of Recommended Practice “Accounting by Limited Liability Partnerships”.

Whilst some of the recognition, measurement, presentation and disclosure requirements and accounting policies that Taycare Health (Management) LLP can make under the Statement of Recommended Practice “Accounting by Limited Liability Partnerships” and FRS 102 may differ from previous UK GAAP, the accounting policies adopted by members are consistent with previous UK GAAP. Consequently, the only changes the members have made on transition to the Statement of Recommended Practice “Accounting by Limited Liability Partnerships” and FRS 102 relate to the presentation and disclosure of the primary statements and notes.

There has been no impact on the financial position or financial performance as shown under previous UK GAAP at the time of transition to the Statement of Recommended Practice “Accounting by Limited Liability Partnerships” and FRS 102 or in the comparative period. Consequently, Taycare Health (Management) LLP has not presented the reconciliations and descriptions of the effect of the transition to FRS 102 on the basis that the members have taken advantage of exemptions to retrospective application of FRS 102, permitted by Chapter 35 of FRS 102, “Transition to this FRS”: (i) equity at the date of transition to FRS 102; (ii) equity at the end of the comparative period; and (iii) profit or loss for the comparative period reported under previous UK GAAP.

TAYCARE HEALTH (MANAGEMENT) LLP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Statement of compliance
(Continued)
- 10 -

Capital

The capital requirements of the limited liability partnership are determined from time to time by the partnership. No interest is payable by the LLP in respect of any members’ capital contributions.

No capital shall be withdrawn by any member without the unanimous consent of all other members.

Allocation of profits and drawings

Each member shall be entitled to share in the net profits pro rata to the amount of their respective capital contribution.

The LLP may at anytime during a financial year make such allocations and distributions to the member on account of the anticipated net profits for that financial year as the LLP Board may resolve and the members may unanimously approve.

In the event that, following signing of the annual accounts, it is apparent that any over-allocation of net profits for that financial year have been made to any member, the amount of such over-allocation shall be debited to the current account of that member.

 

1.2
Going concern

At the time of approving the financial statements, the members have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the members continue to adopt the going concern basis of accounting in preparing the financial statements.

 

1.3
Turnover

Turnover represents fees for services provided to Taycare Health Limited and is recognised in the appropriate financial period. Turnover is represented net of VAT.

 

2
Revenue Recognition

An analysis of the limited liability partnership's turnover is as follows:

2023
2022
£
£
Service fee
706,496
655,837
706,496
655,837

The whole of the turnover is attributable to the principal activity of the limited liability partnership, undertaken in the UK.

 

3
Operating expenses
2023
2022
£
£
Operating expenses
706,496
655,837
4
Auditor's remuneration

The LLPs audit fee is borne by Taycare Health Limited.

TAYCARE HEALTH (MANAGEMENT) LLP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 11 -
5
Debtors
2023
2022
Amounts falling due within one year:
£
£
Trade debtors
312,415
-
2023
2022
Amounts falling due after more than one year:
£
£
Amounts due from subsidiary undertaking
100
100
Total debtors
312,515
100
6
Other creditors falling due within one year
2023
2022
£
£
Other creditors
312,415
-
7
Reconciliation of Members' Interests
Members' capital
Profit and loss reserve
Total members' interest
£
£
£
Members' interests at 1 April 2022
100
-
100
Members' interests at 31 March 2023
100
-
100
TAYCARE HEALTH (MANAGEMENT) LLP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 12 -
8
Related party transactions

During the year the limited liability partnership entered into the following transactions with related parties:

Expenditure
Expenditure
Creditor
Creditor
Management Services
2023
2022
2023
2022
£
£
£
£
Cobalt CPI Limited
274,667
253,908
156,208
-
Cobalt Project Investments (Taycare) Limited
274,667
253,908
156,208
-
Income
Income
Debtor
Debtor
2023
2022
2023
2022
£
£
£
£
Taycare Health Limited
706,496
655,837
312,415
-
2023-03-312022-04-01falseCCH SoftwareCCH Accounts Production 2023.300false0SO3028432022-04-012023-03-31SO302843bus:PartnerLLP12022-04-012023-03-31SO302843bus:PartnerLLP22022-04-012023-03-31SO3028432023-03-31SO3028432021-04-012022-03-31SO302843bus:LimitedLiabilityPartnershipLLP2022-04-012023-03-31SO302843bus:FRS1022022-04-012023-03-31SO302843bus:Audited2022-04-012023-03-31SO302843bus:FullAccounts2022-04-012023-03-31xbrli:purexbrli:sharesiso4217:GBP